Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-24,280
Closed -$995K 352
2015
Q4
$995K Sell
24,280
-500
-2% -$27.4K 0.02% 281
2015
Q3
$1.24M Buy
24,780
+1,530
+7% +$82.5K 0.02% 282
2015
Q2
$1.59M Buy
23,250
+3,600
+18% +$250K 0.02% 268
2015
Q1
$1.3M Buy
19,650
+525
+3% +$33.8K 0.02% 274
2014
Q4
$1.22M Sell
19,125
-150
-0.8% -$9.5K 0.02% 275
2014
Q3
$1.39M Buy
19,275
+100
+0.5% +$8K 0.02% 261
2014
Q2
$1.7M Hold
19,175
0.02% 243
2014
Q1
$1.55M Buy
19,175
+3,100
+19% +$232K 0.02% 238
2013
Q4
$1.14M Sell
16,075
-150
-0.9% -$11.3K 0.02% 254
2013
Q3
$1.24M Sell
16,225
-200
-1% -$12.9K 0.02% 242
2013
Q2
$859K Buy
+16,425
New +$841K 0.01% 255

Other funds holding EGN

Boston Trust Walden's EGN Position: Q1 2016 in Review

Boston Trust Walden sold out of Energen (EGN) in Q1 2016, closing a stake of 24,280 shares — an estimated $995K sold.

Boston Trust Walden first reported a position in EGN in Q2 2013 and held it in 11 quarters. The position peaked at $1.7M in Q2 2014. 267 funds tracked by Wall St. Rank hold EGN as of Q1 2016.

  • Boston Trust Walden reported no remaining Energen position as of Q1 2016 after selling out during the quarter.
  • Boston Trust Walden sold 24,280 Energen shares in Q1 2016, an estimated $995K.
  • Boston Trust Walden first reported a position in Energen in Q2 2013 and held it in 11 quarters.
  • Boston Trust Walden's Energen position peaked at $1.7M in Q2 2014.
  • 267 funds tracked by Wall St. Rank held Energen as of Q1 2016.

Based on Boston Trust Walden's 13F filing for Q1 2016, filed 19 Apr 2016.